Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared a post on LinkedIn:
“I’ve had the privilege of visiting China a few times recently, and each trip leaves me more impressed by the incredible innovation happening in oncology R&D. The pace and scale of progress are truly remarkable.
A friend recently recommended Dan Wang‘s book, ‘Breakneck,’ and it was illuminating. Wang’s concept of China as an ‘engineering state’ one that prioritizes and executes ambitious projects with incredible speed perfectly framed what I was seeing on the ground.
This is more than just an economic observation; it’s a profound source of hope. For those of us dedicated to the fight against cancer, this ‘breakneck’ speed in biotechnology directly translates into the accelerated development of more effective and novel therapies.
It’s a powerful reminder that our ultimate mission of delivering transformative therapies to cancer patients is gaining momentum on a global scale.”
Other articles featuring Walid Kamoun on OncoDaily.